Omeros Corporation
Sector: Manufacturing
Industry: Pharmaceutical Products
6.18
-0.13
(-2.06%)
Volume:
521,705
52 week range:
3.00 - 13.60
Market Cap:
358.835M
Company Description:
Omeros Corporation discovers, develops, and commercializes small-molecule and protein therapeutics. The company's clinical programs include Narsoplimab (OMS721/MASP-2) that has completed pivotal studies for hematopoietic stem-cell transplant-associated thrombotic microangiopathy (HSCT-TMA) and atypical hemolytic uremic syndrome (aHUS) The company was incorporated in 1994 and headquartered in Seattle, Washington.